antidepressants

Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database

Author: Editorial 25th November 2022 0 Comments

“Antidepressants are associated with an increased reporting of withdrawal syndrome compared with other drug classes.” This open-access research article by multiple co-authors has been provided by Springer Link. The abstract says: “Introduction Evidence is lacking on withdrawal syndrome related to individual antidepressants…
Read more

collaborative practice

antidepressants, depression, Pharmacovigilance, Research, Springer Link, withdrawal syndrome, World Health Organisation

Doctor knows best, poisoned chalices, and beings on drugs: Young people’s accounts of getting the diagnosis of bipolar disorder

Author: Editorial 21st November 2022 0 Comments

This account by JP Marshall of part of a research study has been published by Mad in the UK. It begins: “Not long ago, as part of a research study, I asked six young people how it was for them to…
Read more

collaborative practice

antidepressants, biomedical model, bipolar, diagnostic labelling, JP Marshall, Mad in the UK, pharmaceutical industry, psychiatry

Book Review: ‘Evidence-biased Antidepressant Prescription’ by Michael P. Hengartner

Author: Editorial 16th November 2022 0 Comments

This book review by Marion Brown has been published by BJGP Life (which publishes comment and opinion on research and clinical care for the primary care community): “Hengartner begins ‘Over my academic career, I went into different stages of belief and disbelief.’…
Read more

a coherent system

antidepressants, BJGP Life, depression, Diagnostic and Statistical Manual (DSM) of Mental Disorders, DSM, evidence-based practice, Marion Brown, Michael Hengartner, pharmaceutical industry, psychiatry

“Clear evidence” for serotonin hypothesis of depression?

Author: Editorial 7th November 2022 0 Comments

This post by Dr. Eiko Fried has been published on his blog site Measurement, modeling & complexity of mental health. It begins: “There has been a 60 year long discussion on the role of the neurotransmitter serotonin in the pathophysiology of…
Read more

a coherent system

antidepressants, depression, Eiko Fried, Joanna Moncrieff, Research, serotonin, serotonin hypothesis, SSRI, statistics

Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants’ Efficacy and Harm

Author: Editorial 2nd November 2022 0 Comments

This paper by Michael Hengartner has been published in the journal Frontiers in Psychiatry. The abstract says: “Background In current psychiatric practice, antidepressants are widely and with ever-increasing frequency prescribed to patients. However, several scientific biases obfuscate estimates of antidepressants’ efficacy…
Read more

a coherent system

antidepressants, bias, depression, efficacy, evidence-based practice, Frontiers in Psychiatry, harms, Michael Hengartner, Research, selective serotonin reuptake inhibitors, serious adverse events, SSRIs, suicide

Celexa, Lexapro & the Death of Evidence-Based Medicine

Author: Editorial 28th October 2022 0 Comments

This article has been published on the website of American legal firm Baum Hedlund Aristei & Goldman. It begins: “‘Oh, what a tangled web we weave. When first we practise to deceive!” From Walter Scott’s epic poem, Marmion. This is the story of…
Read more

a coherent system

antidepressants, Baum Hedlund Aristei & Goldman, celexa, citalopram, evidence-based medicine, Lexapro, pharmaceutical industry, SSRIs, USA

More treatment but no less depression: The treatment-prevalence paradox

Author: Editorial 24th October 2022 0 Comments

This article – by Johan Orme, Steven D. Hollon, Ronald C. Kessler, Pim Cuijpers, and Scott M. Monroe – has been published in the Clinical Psychology Review. The abstract says: “Treatments for depression have improved, and their availability has markedly increased…
Read more

a coherent system

antidepressants, Clinical Psychology Review, depression, Johan Orme, Pim Cuijpers, Ronald Kessler, Scott Monroe, Steven Hollon, treatment-prevalence paradox

Most people on antidepressants don’t need them: time to wean them off

Author: Editorial 21st October 2022 0 Comments

This leader-article comes from The Economist. It begins: “Almost 35 years ago American drug regulators approved Prozac, the first in a series of blockbuster antidepressants known as selective serotonin re-uptake inhibitors (SSRIs). Prozac and its cousins were lauded by patients and…
Read more

a wellbeing society

antidepressants, drug trials, placebo effect, Prozac, selective serotonin re-uptake inhibitors, SSRI, The Economist

The hidden epidemic of sexual dysfunction which experts blame on SSRI antidepressants

Author: Editorial 3rd October 2022 0 Comments

Jo Macfarlane reports for the Mail on Sunday: SSRI antidepressants could cause ‘life-changing’ sexual problems experts say1 in 8 people were prescribed antidepressants in the past year according to statsBut they can cause serious side effects like libido drop and numb groin…
Read more

collaborative practice

antidepressants, anxiety, Jo Macfarlane, Mail on Sunday, sexual dysfunction, SSRIs

Antidepressants Work Better Than Sugar Pills Only 15 Percent of the Time

Author: Editorial 23rd September 2022 0 Comments

This article by Adam Piore has been published in Newsweek magazine. It begins: “Five years ago Mark Horowitz seemed an unlikely skeptic of psycho-pharmaceuticals. He had been taking the popular antidepressant Lexapro virtually every day for 15 years. He was so…
Read more

collaborative practice

Adam Piore, antidepressants, chemical imbalance theory, Mark Horowitz, Newsweek magazine, placebo effect, psychiatry, SSRIs

Looking for fresh articles?